爵士製藥公司
US ˙ NasdaqGS ˙ IE00B4Q5ZN47

SecurityJAZZ / Jazz Pharmaceuticals plc
InstitutionMorgan Stanley
Latest Disclosed Ownership698,738 shares
Latest Disclosed Value $ 132,096,707
Morgan Stanley reports 9.32% increase in ownership of JAZZ / Jazz Pharmaceuticals plc

On May 15, 2026 - Morgan Stanley filed a 13F-HR form disclosing ownership of 698,738 shares of Jazz Pharmaceuticals plc (US:JAZZ) valued at $132,096,419 USD as of March 31, 2026. The current value of the position is $167,739,044 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F JAZZ PHARMACEUTICALS SHS USD G50871105 698,738 59,559 9.32 132,097 21.57 0.0080
2026-05-27 2025-12-31 13F/A-1 JAZZ PHARMACEUTICALS SHS USD G50871105 639,179 -78,446 -10.93 108,661 14.88 0.0065
2026-02-13 2025-12-31 13F JAZZ PHARMACEUTICALS SHS USD G50871105 639,179 -78,446 108,661 0.0065
2026-05-27 2025-09-30 13F/A-1 JAZZ PHARMACEUTICALS SHS USD G50871105 717,625 -248,122 -25.69 94,583 -7.71 0.0057
2025-11-14 2025-09-30 13F JAZZ PHARMACEUTICALS SHS USD G50871105 717,625 -248,122 94,583 0.0057
2025-08-15 2025-06-30 13F JAZZ PHARMACEUTICALS SHS USD G50871105 965,747 204,151 26.81 102,485 8.39 0.0067
2025-05-15 2025-03-31 13F JAZZ PHARMACEUTICALS SHS USD G50871105 761,596 100,601 15.22 94,552 16.16 0.0068
2025-05-15 2024-12-31 13F/A-1 JAZZ PHARMACEUTICALS SHS USD G50871105 660,995 -83,940 -11.27 81,402 -1.92 0.0057
2025-02-14 2024-12-31 13F JAZZ PHARMACEUTICALS SHS USD G50871105 660,995 -83,940 81,402 0.0057
2025-05-14 2024-09-30 13F/A-2 JAZZ PHARMACEUTICALS SHS USD G50871105 744,935 29,319 4.10 82,993 8.66 0.0060
2025-02-14 2024-09-30 13F/A-1 JAZZ PHARMACEUTICALS SHS USD G50871105 744,935 29,319 82,993 0.0060
2024-11-14 2024-09-30 13F JAZZ PHARMACEUTICALS SHS USD G50871105 744,935 29,319 82,993 0.0060
2025-05-14 2024-06-30 13F/A-2 JAZZ PHARMACEUTICALS SHS USD G50871105 715,616 -243,489 -25.39 76,378 -33.87 0.0059
2024-10-17 2024-06-30 13F/A-1 JAZZ PHARMACEUTICALS SHS USD G50871105 715,616 -243,489 76,378 0.0059
2024-08-14 2024-06-30 13F JAZZ PHARMACEUTICALS SHS USD G50871105 715,616 -243,489 76,378 0.0059
2024-10-17 2024-03-31 13F/A-2 JAZZ PHARMACEUTICALS SHS USD G50871105 959,105 180,302 23.15 115,496 20.57 0.0093
2024-08-16 2024-03-31 13F/A-1 JAZZ PHARMACEUTICALS SHS USD G50871105 959,105 180,302 115,496 0.0093
2024-05-15 2024-03-31 13F JAZZ PHARMACEUTICALS SHS USD G50871105 959,105 180,302 115,496 0.0093
2024-08-16 2023-12-31 13F/A-1 JAZZ PHARMACEUTICALS SHS USD G50871105 778,803 -37,014 -4.54 95,793 -9.29 0.0084
2024-02-13 2023-12-31 13F JAZZ PHARMACEUTICALS SHS USD G50871105 778,803 -37,014 95,793 0.0084
2023-11-15 2023-09-30 13F JAZZ PHARMACEUTICALS SHS USD G50871105 815,817 35,456 4.54 105,599 9.16 0.0107
2023-08-14 2023-06-30 13F JAZZ PHARMACEUTICALS SHS USD G50871105 780,361 42,370 5.74 96,741 -10.42 0.0095
2023-05-15 2023-03-31 13F JAZZ PHARMACEUTICALS SHS USD G50871105 737,991 33,998 4.83 107,990 -3.71 0.0116
2023-02-14 2022-12-31 13F JAZZ PHARMACEUTICALS SHS USD G50871105 703,993 28,383 4.20 112,153 24.54 0.0127
2022-11-14 2022-09-30 13F JAZZ PHARMACEUTICALS SHS USD G50871105 675,610 13,955 2.11 90,052 -12.76 0.0123
2022-10-27 2022-06-30 13F/A-1 JAZZ PHARMACEUTICALS SHS USD G50871105 661,655 197,519 42.56 103,225 42.87 0.0134
2022-08-15 2022-06-30 13F JAZZ PHARMACEUTICALS SHS USD G50871105 661,655 197,519 103,225 0.0134
2022-10-27 2022-03-31 13F/A-1 JAZZ PHARMACEUTICALS SHS USD G50871105 464,136 -85,734 -15.59 72,252 3.14 0.0097
2022-05-13 2022-03-31 13F JAZZ PHARMACEUTICALS SHS USD G50871105 464,136 -85,734 72,252 0.0097
2022-02-14 2021-12-31 13F JAZZ PHARMACEUTICALS SHS USD G50871105 549,870 -98,489 -15.19 70,054 -17.02 0.0087
2021-11-15 2021-09-30 13F JAZZ PHARMACEUTICALS SHS USD G50871105 648,359 148,000 29.58 84,423 -5.02 0.0114
2021-08-23 2021-06-30 13F/A-1 JAZZ PHARMACEUTICALS SHS USD G50871105 500,359 224,068 81.10 88,884 95.72 0.0117
2021-08-16 2021-06-30 13F JAZZ PHARMACEUTICALS SHS USD G50871105 500,359 224,068 88,884 0.0024
2021-05-17 2021-03-31 13F JAZZ PHARMACEUTICALS SHS USD G50871105 276,291 -1,032 -0.37 45,414 -0.78 0.0067
2021-02-16 2020-12-31 13F JAZZ PHARMACEUTICALS SHS USD G50871105 277,323 66,429 31.50 45,771 52.20 0.0071
2020-11-13 2020-09-30 13F JAZZ PHARMACEUTICALS SHS USD G50871105 210,894 40,558 23.81 30,072 60.00 0.0058
2020-08-14 2020-06-30 13F JAZZ PHARMACEUTICALS SHS USD G50871105 170,336 -69,989 -29.12 18,795 -21.59 0.0042
2020-05-26 2020-03-31 13F/A-1 JAZZ PHARMACEUTICALS SHS USD G50871105 240,325 -37,443 -13.48 23,970 -42.19 0.0065
2020-05-15 2020-03-31 13F JAZZ PHARMACEUTICALS SHS USD G50871105 240,325 -37,443 23,970 1,841.3957
2020-02-14 2019-12-31 13F JAZZ PHARMACEUTICALS SHS USD G50871105 277,768 -4,784 -1.69 41,465 14.52 0.0096
2019-11-14 2019-09-30 13F JAZZ PHARMACEUTICALS SHS USD G50871105 282,552 -658 -0.23 36,207 -10.32 0.0096
2019-08-14 2019-06-30 13F JAZZ PHARMACEUTICALS SHS USD G50871105 283,210 34,451 13.85 40,373 13.53 0.0107
2019-05-15 2019-03-31 13F JAZZ PHARMACEUTICALS SHS USD G50871105 248,759 -94,615 -27.55 35,560 -16.46 0.0101
2019-02-14 2018-12-31 13F JAZZ PHARMACEUTICALS SHS USD G50871105 343,374 -13,978 -3.91 42,564 -29.16 0.0127
2019-04-23 2018-09-30 13F/A-2 JAZZ PHARMACEUTICALS SHS USD G50871105 357,352 1,459 0.41 60,081 -2.02 0.0150
2018-11-20 2018-09-30 13F/A-1 JAZZ PHARMACEUTICALS SHS USD G50871105 357,352 0 60,081 0.0150
2018-11-14 2018-09-30 13F JAZZ PHARMACEUTICALS SHS USD G50871105 357,352 1,459 60,081
2019-04-23 2018-06-30 13F/A-1 JAZZ PHARMACEUTICALS SHS USD G50871105 355,893 83,177 30.50 61,320 48.91 0.0166
2018-08-14 2018-06-30 13F JAZZ PHARMACEUTICALS SHS USD G50871105 355,893 83,177 61,320
2019-04-23 2018-03-31 13F/A-1 JAZZ PHARMACEUTICALS SHS USD G50871105 272,716 31,923 13.26 41,178 27.00 0.0114
2018-05-14 2018-03-31 13F JAZZ PHARMACEUTICALS SHS USD G50871105 272,716 31,923 41,178
2019-04-23 2017-12-31 13F/A-1 JAZZ PHARMACEUTICALS SHS USD G50871105 240,793 -1,927 -0.79 32,423 -8.66 0.0089
2018-02-14 2017-12-31 13F JAZZ PHARMACEUTICALS SHS USD G50871105 240,793 -1,927 32,423
2017-11-14 2017-09-30 13F JAZZ PHARMACEUTICALS SHS USD G50871105 242,720 -131,015 -35.06 35,498 -38.92 0.0106
2017-08-11 2017-06-30 13F JAZZ PHARMACEUTICALS SHS USD G50871105 373,735 -7,357 -1.93 58,116 5.08 0.0176
2017-05-22 2017-03-31 13F/A-1 JAZZ PHARMACEUTICALS SHS USD G50871105 381,092 3,228 0.85 55,309 34.25 0.0170
2017-05-12 2017-03-31 13F JAZZ PHARMACEUTICALS SHS USD G50871105 381,092 55,309
2017-02-22 2016-12-31 13F/A-1 JAZZ PHARMACEUTICALS SHS USD G50871105 377,864 60,453 19.05 41,199 6.85 0.0135
2017-02-13 2016-12-31 13F JAZZ PHARMACEUTICALS SHS USD G50871105 377,864 41,199
2016-11-10 2016-09-30 13F JAZZ PHARMACEUTICALS SHS USD G50871105 317,411 -63,290 -16.62 38,559 -28.33 0.0132
2016-08-12 2016-06-30 13F JAZZ PHARMACEUTICALS SHS USD G50871105 380,701 135,239 55.10 53,798 67.88 0.0194
2016-05-12 2016-03-31 13F JAZZ PHARMACEUTICALS SHS USD G50871105 245,462 25,234 11.46 32,045 3.52 0.0123
2016-02-09 2015-12-31 13F JAZZ PHARMACEUTICALS SHS USD G50871105 220,228 -25,366 -10.33 30,955 -5.09 0.0112
2016-02-08 2015-09-30 13F/A-1 JAZZ PHARMACEUTICALS SHS USD G50871105 245,594 -114,777 -31.85 32,616 -48.60 0.0121
2015-11-09 2015-09-30 13F JAZZ PHARMACEUTICALS SHS USD G50871105 245,594 32,616
2015-08-12 2015-06-30 13F JAZZ PHARMACEUTICALS SHS USD G50871105 360,371 -44,433 -10.98 63,450 -9.29 0.0220
2015-05-14 2015-03-31 13F JAZZ PHARMACEUTICALS SHS USD G50871105 404,804 -57,498 -12.44 69,947 -7.59 0.0258
2015-02-13 2014-12-31 13F JAZZ PHARMACEUTICALS SHS USD G50871105 462,302 9,179 2.03 75,692 4.04 0.0277
2014-12-16 2014-09-30 13F/A-1 JAZZ PHARMACEUTICALS SHS USD G50871105 453,123 84,991 23.09 72,753 34.43 0.0280
2014-11-14 2014-09-30 13F JAZZ PHARMACEUTICALS SHS USD G50871105 453,123 72,753
2014-08-12 2014-06-30 13F JAZZ PHARMACEUTICALS SHS USD G50871105 368,132 -130,760 -26.21 54,118 -21.78 0.0926
2014-05-13 2014-03-31 13F JAZZ PHARMACEUTICALS SHS USD G50871105 498,892 153,093 44.27 69,186 58.09 0.0290
2014-02-13 2013-12-31 13F JAZZ PHARMACEUTICALS SHS USD G50871105 345,799 -28,629 -7.65 43,764 27.09 0.0186
2013-11-13 2013-09-30 13F JAZZ PHARMACEUTICALS INC COM G50871105 374,428 84,685 29.23 34,435 72.92 0.0163
2013-08-08 2013-06-30 13F JAZZ PHARMACEUTICALS INC COM G50871105 289,743 289,743 19,914 0.0100
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.